You are here

Kathleen C.M. Campbell, PhD

Research Professor, Distinguished Scholar

About

Contact
phone: 217.545.7310
kcampbell@siumed.edu

Kathleen Campbell, Ph.D., Distinguished Scholar and Research Professor in the Department of Medical Microbiology, Immunology and Cell Biology at SIU School of Medicine, served on the American Academy (AAA) Board of Directors, received an AAA Presidential Citation, two Medical Innovators Awards and is an American Speech Language Hearing Association (ASHA) fellow. She was the 2012 Inventor of the Year for the Southern Illinois University System. She was named university-wide Distinguished Scholar for 2014.She authored Essential Audiology for Physicians and edited/authored Pharmacology and Ototoxicity for Audiologists. She has received more than 60 grants from NIH and other agencies for her research in otoprotective agents and is the inventor of the protective agent D-methionine patents. Her patents are owned by her employer, SIU School of Medicine.

Research Interests

Her research is focused on ototoxicity and otoprotective agents. She has served as principal investigator on more than 60 research grants, funded by agencies such as the Department of Defense, Veterans Administration, the Illinois Department of Public Health and the National Institutes of Health/National Institute of Aging and National Institute of Deafness and Communication Disorders.

General Laboratory Techniques:

Auditory Electrophysiologic Measures, Noise exposures, Spectrophotometry, Enzyme Analyses

Education

School: 
1989 Ph.D., University of Iowa, Audiology/Hearing Science, 1977 M.A., University of South Dakota, Audiology, 1973 B.A., South Dakota State University, Communication/Education

Grants

2015-2020       R01 DC014549-01 NIDCD/NIH entitled “Optimizing D-methionine (D-met) Pre-loading and Rescue Dosing Through Functional and        Biomarker Measures”. April 1, 2015 through March 31, 2020 $2,816,808.00  PI. Kathleen Campbell, PhD

Patents

“Therapeutic Use of D-Methionine to Reduce the Toxicity of Platinum-Containing Anti-Tumor Compounds”  Inventor:  Kathleen Campbell, U.S. Patent Application Serial No. 08/942,845, SIU File #7356.  Issued February 13, 2001

“Therapeutic Use of D-methionine to Reduce the Toxicity of Ototoxic Drugs, Noise and Radiation”  Inventor Kathleen C.M. Campbell, Patent No: 6,265,386 B1.  Date of Patent July 24, 2001

“Therapeutic Use of D-Methionine to Reduce the Toxicity of Noise” Inventor:  Kathleen C. M. Campbell,  Patent No. 7,071,230 Date of Patent July 4, 2006

“ Therapeutic Use of Methionine-Derivatives to Reduce the Toxicity of Noise” U.S. Patent # 7,423,065 Application No. 11/324,744 issued September 9,2008

“Therapeutic Use of D-methionine to Reduce the Toxicity of Ototoxic Drugs, Noise, and Radiation” European Patent No. 98915362.2 Date of Patent June 25, 2003

Tabs